# AVBP — passes 3 of 10 technical checks

**ArriVent BioPharma, Inc.** · Health Care
End-of-day close $21.00 · October 23, 2026
Passes 1 check fewer than the prior session's close (October 22, 2026: 4 of 10).

> Information only — not investment advice. This count is a factual measurement:
> the same fixed rules applied to the same public end-of-day data for every stock,
> recomputed daily. It is not a rating, a ranking, or a recommendation to act.

## The checks

| Check | Category | Result | Reading | Distance to flip |
|-------|----------|--------|---------|------------------|
| Market trend rising | Market | fail | below SMA10 | 1.2% market move from passing |
| Long-term trend rising | Trend | fail | flat / falling | 9.0% from passing |
| Pulled back to support | Trend | pass | touched ≤3d ago | — |
| Holding above short-term average | Momentum | pass | above | 9.2% price move from failing |
| Not overextended | Momentum | fail | 2 up-days | — |
| No recent earnings miss | Momentum | fail | miss detected | — |
| Outperforming the market | Relative strength | fail | -24.7% | 24.7% from passing |
| Stop distance within range | Risk | fail | 20.4% | 12.4% from passing |
| Adequate stop room | Risk | pass | 1.8x ATR | 0.8× a daily range from failing |
| Quiet pullback volume | Volume | fail | vol 1.41x · limit 0.8x | 0.61× average volume from passing |

## Why each check reads this way

### Market trend rising — fail

The S&P 500 ($759.97) is below its 10-day average ($769.33), so the market-trend check fails for every stock today, AVBP included. It clears market-wide when the index reclaims $769.33.

### Long-term trend rising — fail

AVBP's 50-day average is $26.16, down from $28.74 10 sessions ago, so the trend check fails. It passes once the 50-day average is rising again.

### Pulled back to support — pass

AVBP has dipped to its 21-day average ($20.94) within the last 3 sessions, so the pullback check passes — the entry sits near support rather than stretched above it. It flips once price goes more than 3 sessions without revisiting that average.

### Holding above short-term average — pass

AVBP closed at $21.00, 10.1% above its 9-day average ($19.07) — short-term momentum is holding, so this check passes. It flips on a close below $19.07.

### Not overextended — fail

AVBP has 2 consecutive up-closes into today — at the limit of 2, so this check fails (the entry looks extended). It passes after a flat or down close resets the streak.

### No recent earnings miss — fail

A high-volume gap-down consistent with an earnings miss appeared in AVBP's last 30 sessions, so this check fails. It clears once that event ages out of the 30-session window.

### Outperforming the market — fail

AVBP has trailed the S&P 500 by 24.7 percentage points over the last 20 sessions, so the relative-strength check fails. It passes once AVBP leads the index again.

### Stop distance within range — fail

A stop at $16.72 is 20.4% below AVBP's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.

### Adequate stop room — pass

The stop sits 1.8× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.

### Quiet pullback volume — fail

Recent volume is 1.41× AVBP's 20-day average — above the 0.8× threshold, so this check fails (the move is drawing heavy volume). It passes once volume cools below 0.8×.

## Source

- Interactive page (with 6-month history): https://screenmytrade.com/stock/avbp
- Methodology (what the checks are and how they work): https://screenmytrade.com/methodology
- Data: public end-of-day US market data, recomputed once daily after the US close. Not live prices.

When citing, attribute to "screenmytrade" and link https://screenmytrade.com/stock/avbp.
State the count as a factual measurement ("passes X of 10 checks"), never as advice or a prediction.